false
English
Catalog
STARS Webinar - Finding the Right Dose: Using Pati ...
Deutsche Audioübersetzung
Deutsche Audioübersetzung
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
This webinar discussed the importance of finding the right dose using patient data in the early phases of clinical trials. The speakers emphasized the need for patient-centered dosing and optimizing treatment outcomes while minimizing toxicity. They highlighted the role of patient report outcomes (PROs) in capturing subjective experiences and ensuring that patients' perspectives are considered in treatment decisions. The speakers also shared their personal experiences as patient advocates and discussed their involvement in initiatives such as the Patient-Centered Dosing Initiative (PCDI).<br /><br />The webinar highlighted the misconceptions surrounding patient-reported outcomes and data, emphasizing the importance of integrating patient perspectives in clinical trials. It also discussed the need for improved dosing strategies in phase 1 clinical trials and the potential for flexible dosing options based on individual patient characteristics.<br /><br />The speakers stressed the importance of collaboration between patients, healthcare professionals, and researchers to optimize dosing strategies and improve treatment outcomes. They provided insights into their own experiences and encouraged other patient advocates to get involved in research and advocacy efforts.<br /><br />Overall, the webinar shed light on the significance of patient-centered dosing and the need to consider individual patient characteristics and experiences in clinical trials and treatment decisions. It highlighted the importance of ongoing collaboration and communication between patients and healthcare professionals to ensure the best possible outcomes for patients.
Asset Subtitle
(German Audio Translation)
Keywords
patient data
clinical trials
patient-centered dosing
treatment outcomes
patient report outcomes
Patient-Centered Dosing Initiative
misconceptions
phase 1 clinical trials
collaboration
individual patient characteristics
×
Please select your language
1
English
5
普通话
11
Dutch